[go: up one dir, main page]

NO943543D0 - Farmasöytisk bæresystem inneholdende definerte lipider - Google Patents

Farmasöytisk bæresystem inneholdende definerte lipider

Info

Publication number
NO943543D0
NO943543D0 NO943543A NO943543A NO943543D0 NO 943543 D0 NO943543 D0 NO 943543D0 NO 943543 A NO943543 A NO 943543A NO 943543 A NO943543 A NO 943543A NO 943543 D0 NO943543 D0 NO 943543D0
Authority
NO
Norway
Prior art keywords
pct
carrier system
system containing
pharmaceutical carrier
lipid
Prior art date
Application number
NO943543A
Other languages
English (en)
Other versions
NO943543L (no
NO308984B1 (no
Inventor
Haakan Nyqvist
Gert Anders Ragnarsson
Per Tingvall
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of NO943543L publication Critical patent/NO943543L/no
Publication of NO943543D0 publication Critical patent/NO943543D0/no
Publication of NO308984B1 publication Critical patent/NO308984B1/no

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO943543A 1992-03-27 1994-09-23 Farmasøytisk bærersystem inneholdende definerte lipider, samt preparat av samme NO308984B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9200952A SE9200952D0 (sv) 1992-03-27 1992-03-27 Pharmaceutical carrier system containing defined lipids
PCT/SE1993/000257 WO1993019736A1 (en) 1992-03-27 1993-03-26 A pharmaceutical carrier system containing defined lipids

Publications (3)

Publication Number Publication Date
NO943543L NO943543L (no) 1994-09-23
NO943543D0 true NO943543D0 (no) 1994-09-23
NO308984B1 NO308984B1 (no) 2000-11-27

Family

ID=20385758

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943543A NO308984B1 (no) 1992-03-27 1994-09-23 Farmasøytisk bærersystem inneholdende definerte lipider, samt preparat av samme

Country Status (10)

Country Link
US (1) US5635205A (no)
EP (1) EP0636020B1 (no)
JP (1) JPH07508708A (no)
AT (1) ATE179885T1 (no)
DE (1) DE69324914T2 (no)
DK (1) DK0636020T3 (no)
FI (1) FI114140B (no)
NO (1) NO308984B1 (no)
SE (1) SE9200952D0 (no)
WO (1) WO1993019736A1 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665379A (en) * 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
SE9402453D0 (sv) * 1994-07-12 1994-07-12 Astra Ab New pharmaceutical preparation
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
EP0770387B1 (en) * 1995-10-28 1999-08-11 B. Braun Melsungen Ag Pharmaceutical composition containing a local anesthetic and/or centrally acting analgesic
EP0975331A1 (en) * 1997-04-17 2000-02-02 Dumex-Alpharma A/S A novel bioadhesive drug delivery system based on liquid crystals
PT1014946E (pt) 1997-09-18 2010-07-06 Pacira Pharmaceuticals Inc COMPOSIÎES ANESTéSICAS LIPOSSOMAIS DE LIBERTAÆO SUSTENTADA
ATE554748T1 (de) 1997-11-14 2012-05-15 Pacira Pharmaceuticals Inc Herstellung von multivesikulären liposomen
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
NZ509186A (en) 1998-07-17 2005-01-28 Skyepharma Inc Biodegradable compositions for the controlled release of encapsulated substances
ES2211151T3 (es) 1998-08-19 2004-07-01 Skyepharma Canada Inc. Dispersiones acuosas inyectables de propofol.
EE200100342A (xx) 1998-12-23 2002-10-15 Idea Ag Parendatud ravimvorm in vivo mitteinvasiivseks paikseks rakendamiseks
MXPA02000053A (es) 1999-07-05 2003-07-21 Idea Ag Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
JP2004532252A (ja) * 2001-05-31 2004-10-21 スカイファーマ インコーポレーテッド リポソームおよびミクロスフェア中のナノ懸濁物のカプセル化
US20040105881A1 (en) 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
USRE46397E1 (en) 2007-11-07 2017-05-09 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
US20140066481A1 (en) * 2010-04-01 2014-03-06 Pharmanest Ab Water-Free Pharmaceutical Compositions Suitable for Local Anaesthetics
CA2871821C (en) * 2012-05-10 2021-01-12 Painreform Ltd. Depot formulations of a local anesthetic and methods for preparation thereof
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
WO2014134586A2 (en) 2013-02-28 2014-09-04 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid formulations and its compostions
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12285419B2 (en) 2021-10-14 2025-04-29 Pacira Pharmaceuticals, Inc. Bupivacaine multivesicular liposome formulations and uses thereof
US12251468B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12246092B1 (en) 2024-05-20 2025-03-11 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
DE3585967D1 (de) * 1984-03-08 1992-06-11 Phares Pharma Holland Liposombildende zusammensetzung.
US5059421A (en) * 1985-07-26 1991-10-22 The Liposome Company, Inc. Preparation of targeted liposome systems of a defined size distribution
SE9003100D0 (sv) * 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system

Also Published As

Publication number Publication date
FI944441L (fi) 1994-09-26
US5635205A (en) 1997-06-03
JPH07508708A (ja) 1995-09-28
EP0636020B1 (en) 1999-05-12
SE9200952D0 (sv) 1992-03-27
NO943543L (no) 1994-09-23
ATE179885T1 (de) 1999-05-15
FI944441A0 (fi) 1994-09-26
NO308984B1 (no) 2000-11-27
DE69324914D1 (de) 1999-06-17
WO1993019736A1 (en) 1993-10-14
EP0636020A1 (en) 1995-02-01
DE69324914T2 (de) 1999-12-09
FI114140B (fi) 2004-08-31
DK0636020T3 (da) 1999-11-15

Similar Documents

Publication Publication Date Title
DK0636020T3 (da) Farmaceutisk bærersystem indeholdende definerede lipider
DK398587A (da) Antitumorvirksomt laegemiddel
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
EP0788346A4 (en) EMULSION DRUG DELIVERY SYSTEMS
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2123660T3 (es) Composiciones para administracion nasal que contienen metabolitos polares de analgesicos opioides.
DK433584A (da) Middel til transdermal applikation af stoffer, der er virksomme som laegemidler
DE69009185D1 (de) Arzneimittelfreisetzungssystem aus glucan und adjuvant.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
BR9611587A (pt) Processo e composição para tratamento da pele deseres humanos e preparação tópica para aplicação à pele.
ATE154235T1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
ATE210430T1 (de) Arzneiform zur transdermalen verabreichung
ATE137959T1 (de) Liposomale piroxycam formulierung
ES2090703T3 (es) Medicamento agudo que contiene flurbiprofeno y su empleo.
ES2086538T3 (es) Medicamento para el tratamiento de la hiperlipemia y/o aterosclerosis.
CA2129527A1 (fr) Composition pharmaceutique utilisable comme analgesique contenant l'acide (benzoyl-3 phenyl)-2 propionique-(r)
ES2122005T3 (es) Medicamento que contiene (-)-metrifonato.
BR9302809A (pt) Composto,processo para sua preparacao,processo de purificacao dos compostos,medicmanto,emprego e processo para a preparacao de um agente anti-tumoral
CO4600680A1 (es) Procedimientos para la prevencion de la degradacion de la proteina c
ES2188670T3 (es) Formulaciones que contienen codeina.
ES2007040A6 (es) Un forma de dosificacion para descargar un agente benificioso a un entorno fluido de uso
DK0483273T3 (da) Ionoforholdig afgivelsesindretning
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments
EP0305194A3 (en) Veterinary composition

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees